Latest Headlines
Forbes.com - Aug. 18, 2008, 8:07 PM
Zacks.com releases the latest Analyst Interview. Today's interview is with senior analyst Tom Park, who discusses Cepheid (Nasdaq: CPHD), BioSphere Medical (Nasdaq: BSMD) and Immucor (Nasdaq: BLUD). Get the most recent insight from Zacks Equity Research ...
CNBC - Aug. 7, 2008, 6:33 PM
STOCKS, STOCK MARKET, CNBC, CNBC.COM, STOCK BLOG, CNBC STOCK BLOG, INVESTMENT, PORTFOLIO Merrill Lynch, Amgen, and some medical instrument outfits are getting a lot of options action this week, according to one observer. There was a jump in options ...
CNBC - Aug. 4, 2008, 11:10 PM
NEW YORK - AutoGenomics Inc., which makes diagnostic systems that test for genetic and infectious diseases and cancer, is planning an initial public offering of common stock, according to a Securities and Exchange Commission filing on Friday. The ...
Business Week - Aug. 4, 2008, 10:25 PM
getting an injection of investor optimism about the economy on better-than-expected durable goods orders and new home sales figures, while another drop in oil prices offered the markets further hope. On Friday, the Dow Jones industrial average was ...
Forbes.com - Aug. 4, 2008, 9:22 PM
AutoGenomics Inc., which makes diagnostic systems that test for genetic and infectious diseases and cancer, is planning an initial public offering of common stock, according to a Securities and Exchange Commission filing on Friday. The Carlsbad, Calif., ...
CNBC - Aug. 4, 2008, 8:11 PM
NEW YORK - Shares of molecular diagnostics company Cepheid plunged Friday after the company reported a wider second-quarter loss and set a weak revenue outlook because of lower-than-expected sales in certain segments. The stock plummeted $9.47, or 34.8 ...
Business Week - Aug. 4, 2008, 7:41 PM
Shares of molecular diagnostics company Cepheid plunged Friday after the company reported a wider second-quarter loss and set a weak revenue outlook because of lower-than-expected sales in certain segments. The stock plummeted $9.47, or 34.8 percent, to ...
Forbes.com - Aug. 4, 2008, 7:18 PM
Shares of molecular diagnostics company Cepheid plunged Friday after the company reported a wider second-quarter loss and set a weak revenue outlook because of lower-than-expected sales in certain segments. The stock plummeted $9.47, or 34.8 percent, to ...
Forbes.com - Aug. 3, 2008, 6:57 AM
LONDON (REUTERS) - REUTERS, Non-S&P Corporate earnings for US companies for Thursday, July 24, 2008. S&P 500 Earnings - Weekly [SP500/WK] S&P 500 Earnings - Day Ahead [ESTEARN/SP] Non S&P 500 - Weekly [NSP500/WK] S&P 500 Earnings - Monthly [RESF/US] ...
Forbes.com - Jul. 17, 2008, 4:47 PM
Pilgrim Software, Inc., a world-leading provider of Enterprise Compliance and Quality Management (ECQM) software solutions, today announced that Cepheid, an on-demand molecular diagnostics company based in Sunnyvale, CA, has selected Pilgrim's ...
